Company: ARMP
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001104659-25-040273
Chunk: 12

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 12
---
 of the holders of shares present in person or represented by proxy and entitled to vote on the election of directors. Accordingly, the seven nominees receiving the highest number of affirmative votes at this annual meeting will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the seven nominees named below. If any nominee becomes unavailable for election as a result of an unexpected occurrence, shares that would have been voted for that nominee will instead be voted for the election of a substitute nominee proposed by the Board of Directors. Each person nominated for election has agreed to serve if elected. The Company’s management has no reason to believe that any nominee will be unable to serve. Under our current Bylaws, any vacancy occurring on the Board of Directors may be filled by the shareholders, the Board of Directors or, if the directors in office constitute fewer than a quorum, by the affirmative vote of a majority of the remaining directors. Our Board of Directors Set forth below are the name, age, position of and biographical information about each nominee, as of the record date.

| Name                             | ​ | ​ | Age | ​ | ​ | Position(s)                       | ​ |
| Deborah L. Birx, M.D.            | ​ | ​ |  69 | ​ | ​ | Chief Executive Officer, Director | ​ |
| Jules Haimovitz(6)               | ​ | ​ |  74 | ​ | ​ | Director                          | ​ |
| Odysseas D. Kostas, M.D.(3)(6)   | ​ | ​ |  51 | ​ | ​ | Director                          | ​ |
| Robin C. Kramer(1)(4)(5)         | ​ | ​ |  60 | ​ | ​ | Director                          | ​ |
| Joseph M. Patti, Ph.D.(2)(3)(4)  | ​ | ​ |  61 | ​ | ​ | Director                          | ​ |
| Todd C. Peterson, Ph.D.(1)(4)    | ​ | ​ |  67 | ​ | ​ | Director                          | ​ |
| Sarah J. Schlesinger, M.D.(2)(3) | ​ | ​ |  65 | ​ | ​ | Director                          | ​ |

(1) Member of the Audit Committee. (2) Member of the Compensation Committee. (3) Member of the Nominating and Corporate Governance Committee. (4) Member of the Special Committee